Intracranial hemangiopericytoma in a child: a case report with MR spectroscopy findings

Koç, Ali Murat; Öner, Ali Yusuf; Uçar, Murat; Börcek, Alp Özgün

doi:10.5137/1019-5149.jtn.8374-14.1

Cited by 4 publications

(6 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The indications for this procedure include: story of excessive bleeding in previous surgery; hypervascularity tumors; deep tumors with hard access on the early surgical access of the main feed vessels; tumors associated with intratumoral aneurysm. However, in HPCs bigger than 6 cm the embolization did not show intraoperative benefits [14][15][16].…”

Section: Discussionmentioning

confidence: 77%

“…It affects 0.34 infants on 1 million born alive. According to the age, the HPCs are graduated in two clinical types: HPC in infants (< 1 year old) and HPC in adults (> 1 year old) [8,9].…”

Section: Discussionmentioning

confidence: 99%

“…Commonly, its symptoms are caused by the mass effect, but it is presented also with focal alterations, headache or convulsions. It rarely presents intracranial bleeding, since only 12 cases were described on the literature [9].…”

Section: Discussionmentioning

confidence: 99%

“…Microscopically, these lesions exhibit intra tumoral bleedind, because during the tumor growing there is erosion of blood vessels, distortion, distention, occlusion and necrosis due to endothelial proliferation. In these particular cases it is necessary the emergency surgery, as occurs in subarachnoid hemorrhage [9].…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Management of Patients with Hemangiopericytoma: Case Report and Literature Review

Cardoso¹

2019

AJHR

View full text Add to dashboard Cite

The hemangiopericytomas (HPCs) are rare tumors of the dural base and correspond of less than 1% of all primary Central Nervous System (CNS) tumors. It usually affects adult males with 40 to 50 years old and has a supratentorial location (70%), followed by posterior fossa (15%) and spine (15%). Generally, it has fast progression and manifests clinically through headache, focal neurological deficits and epileptic seizures. The tumor has high incidence of local recurrence, from 34% to 90%, and it is estimated that the follow-up of these patients should be done for at least 7, 5 years. The percentage of longdistance metastases is lower, 12% to 55%, affecting especially bones, lungs and liver, in decreasing order. The objective of this study is to evaluate the contradictions when approaching these tumors and to analyze a rare case of pediatric involvement. It was prepared a case report and a literature review was made using the data bases MEDLINE®, PubMed and Cochrane, where 31 relevant articles were selected related to the proposed study. The outcome of HPC treatment can change according to the tumor's location in the CNS or extracranial, the tumor's size and the histopathological classification. Therefore, many studies have been proposed observing the answer of the surgical resection, the adjuvant radiotherapy, the radiosurgery and the antiangiogenic therapies.

show abstract

Section: Discussionmentioning

confidence: 77%

“…It affects 0.34 infants on 1 million born alive. According to the age, the HPCs are graduated in two clinical types: HPC in infants (< 1 year old) and HPC in adults (> 1 year old) [8,9].…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Management of Patients with Hemangiopericytoma: Case Report and Literature Review

Cardoso¹

2019

AJHR

View full text Add to dashboard Cite

show abstract

“…On the microscopic level, the lesions show intratumor bleeding, because during the growth of the tumor, the consequences are: erosion of blood vessels, distortion, distension, occlusion and necrosis due to endothelial proliferation. In these special cases, emergency rescue surgery is required, as occurs in the case of subarachnoid hemorrhage [ 7 ].…”

Section: Discussionmentioning

confidence: 99%

Hemangiopericytoma of the central nervous system: a case report

Moukhlissi¹,

Elouaouch²,

Aichouni³

et al. 2023

Pan Afr Med J

View full text Add to dashboard Cite

Hemangiopericytomas or solitary meningeal fibrous tumors are extremely rare mesenchymal tumors. They represent only 1.6% of all central nervous system tumors, occurring mainly in adults between 40 and 50 years of age with a slight male predominance. We report the observation of a 20-year-old man treated at the Oujda Regional Oncology Center for cerebral hemangiopericytoma, revealed by headaches resistant to usual analgesic treatments without other associated signs. Initial imaging a left temporo-parieto-occipital intraaxial tumor process all responsible for a sub-falcoial and temporal engagement whose appearance first evokes a high-grade glial tumor. The patient received a complete excision whose pathological examination with immunohistochemical study was in favor of a grade III hemangiopericytoma according to the WHO 2016 classification. Therapeutic management with adjuvant radiotherapy was supplemented with a volumetric modulated arc therapy (VMAT) technique at a total dose of 54Gy. We will discuss through this case, the clinical and therapeutic peculiarities by a review of the literature.

show abstract

Case report: neonatal giant forehead hemangiopericytoma with a 5-year follow-up

et al. 2019

View full text Add to dashboard Cite

Rationale: Hemangiopericytoma (HPC) is a rare pediatric neoplasm with a high risk of bleeding, aggressive growth and high early relapse rates. Surgical excision remains the mainstream treatment, while the functions of chemotherapy and radiotherapy remain controversial. In particular, an infantile giant extracranial HPC located in the forehead has never been reported. Patient concerns: A 3-day-old girl was delivered normally with a giant tumor localized mainly in the right frontal region. The surface of the mass was filled with vascularity. Diagnosis: According to the results of imaging and pathological examinations, the diagnosis was HPC grade II. Interventions: Gross total resection of the tumor and the invading partial frontal bone followed by skin scalp reconstruction was carried out without any blood transfusion. Outcomes: No recurrence was identified during 5 years of follow-up. And better outcomes can be achieved without adjuvant therapy. Lessons: Multimodality imaging and a collaborative multidisciplinary approach are indispensable for the successful surgical management of infantile HPC, especially for giant tumors and their potential risk of life-threatening bleeding. Gross total resection is the optimal option for infantile HPC, and even without adjuvant therapy, it achieves better outcomes.

show abstract

Intracranial hemangiopericytoma in a child: a case report with MR spectroscopy findings

Cited by 4 publications

References 7 publications

Management of Patients with Hemangiopericytoma: Case Report and Literature Review

Management of Patients with Hemangiopericytoma: Case Report and Literature Review

Hemangiopericytoma of the central nervous system: a case report

Case report: neonatal giant forehead hemangiopericytoma with a 5-year follow-up

Contact Info

Product

Resources

About